Resistance to Both Chemotherapy and EGFR-TKI in Small Cell Lung Cancer With EGFR 19-Del Mutation: A Case Report

Epidermal growth factor receptor (EGFR) mutations are common in non-small cell lung cancers, but rare in small cell lung cancers (SCLCs). In previous reports, some SCLC patients with EGFR mutations could benefit from EGFR tyrosine kinase inhibitors (TKIs). In this study, we reported a case in which...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lingfei, Dong, Fangyuan, Su, Jie, Du, Guanjun, Shao, Yang, Liu, Ying, He, Xuequn, Bao, Liubin, Wang, Wei, Guo, Xin, Wang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379871/
https://www.ncbi.nlm.nih.gov/pubmed/32766137
http://dx.doi.org/10.3389/fonc.2020.01048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379871/
https://www.ncbi.nlm.nih.gov/pubmed/32766137
http://dx.doi.org/10.3389/fonc.2020.01048

Ejemplares similares